762-25-1-040-0164 -Tucson CMOP DROSPIRENONE -(VA-25-00016553)
ID: 36C77025Q0056Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/0a646069316f4827a77a1451e726e731/view
Timeline
    Description

    The Department of Veterans Affairs is seeking vendors to provide Drosperinone 4MG tablets for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP) under the solicitation number RFQ 36C77025Q0056. Vendors must comply with the Trade Agreements Act and submit a signed Solicitation cover page, a completed quote spreadsheet, proof of a State Wholesale Distributor License, and a Trade Agreement Certificate by the deadline of November 20, 2024, at 4:00 PM CST. The procurement is critical for ensuring the availability of essential pharmaceuticals for veterans, with delivery expected within 10 days after receipt of order and products required to have a minimum one-year shelf life upon delivery. Interested parties can contact Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935 for further information.

    Point(s) of Contact
    Sarah Fry
    (913) 758-9935
    sarah.fry2@va.gov
    Files
    Title
    Posted
    S02_PRE_SOL_Q0056.pdf
    The Department of Veterans Affairs (VA) is releasing a presolicitation notice for the procurement of Drosperinone 4mg tablets for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The solicitation number is 36C77025Q0056, with a response deadline set for November 20, 2024, at 16:00 Central Time. The nature of the procurement falls under a full and open competition, classified under product service code 6505 and NAICS code 325412. Quotations must include several specific documents such as the signed solicitation cover page (SF1449), a pricing schedule, a state wholesale distributor license verifying compliance with the Drug Supply Chain Security Act, and a Trade Agreement Act certificate if applicable. The estimated issue date for this solicitation is November 13, 2024, with delivery expected within 10 days after receipt of order. All responses should be submitted via email to the provided contact, Sarah Fry. This notice underscores the VA's commitment to ensuring compliance and timely procurement to support veteran healthcare needs.
    S02_Pricing Schedule_Q0056.xlsx
    The document outlines a Request for Quotation (RFQ) from the Veterans Affairs (VA) for the Tucson CMOP, identified by RFQ number 36C77025Q0056. Vendors are required to submit their quotes via email by the closing date of November 20, 2024, at 4:00 PM CST. Key deliverables include a signed Solicitation cover page (SF1449), a completed quote spreadsheet, proof of a State Wholesale Distributor License, and a Trade Agreement Certificate. The RFQ specifies that the delivery of pharmaceuticals and medical supplies must occur within 10 days after receipt of order (ARO), with expiration dates extending at least one year from delivery. The document emphasizes the submission limitation of one quote per vendor and provides a detailed structure for the quotation, including necessary product information such as NDC numbers and unit pricing. Additionally, the RFQ references applicable Trade Agreement Acts, guiding the vendor's obligations under federal procurement rules. Overall, it represents the VA’s effort to procure necessary medical supplies, ensuring compliance with deadlines and quality standards while facilitating vendor participation in federal contracting processes.
    S02_RFQ_Q0056.pdf
    The document details a federal Request for Proposal (RFP) regarding the acquisition of pharmaceuticals, specifically Drosperinone 4MG tablets, destined for the Department of Veterans Affairs Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson, AZ. It outlines critical requirements for vendors, including the need for compliance with the Trade Agreements Act (TAA), the necessity for proper labeling with bar codes, and adherence to delivery specifications. Vendors must be registered in the System for Award Management (SAM) and provide various documentation, such as state licenses and pricing schedules. The contract terms include details on invoice submission, payment methods, and the conditions under which goods may be rejected or accepted. Specific clauses regarding contract administration, delivery expectations, and potential contract termination scenarios are also highlighted. Key preferences are given to U.S. made products, with guidelines for shipment logistics and product recalls. Overall, the document serves as a guideline for prospective offerors, emphasizing adherence to federal regulations and the importance of providing pharmaceutical products that meet outlined standards while ensuring operational efficiency in delivery and compliance with safety protocols.
    Similar Opportunities
    6505--Mycophenolate Mofetil RFI
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting market research for the procurement of Mycophenolate Mofetil capsules and tablets, intended for use by multiple federal agencies, including the Department of Defense and the Indian Health Service. The objective is to establish a national mandatory requirements contract that will ensure lower pricing based on committed volume, with a preference for a long-term agreement consisting of a base year and up to four option years. This procurement is crucial for maintaining the availability of essential pharmaceuticals within federal healthcare systems. Interested companies must respond by November 19, 2024, providing specific information such as a unique National Drug Code, evidence of manufacturer relationships, and compliance with distribution agreements. For inquiries, contact Amber Zavala at amber.zavala@va.gov or call 708-786-5160.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0007 for the procurement of Warfarin Tablets, aimed at ensuring a reliable supply for various federal health agencies, including the Department of Defense and the Bureau of Prisons. This unrestricted procurement will cover multiple tablet strengths and packaging sizes, with an estimated annual usage detailed across 16 product types, and will be awarded for an initial one-year period with options for four additional years. The successful contractor must provide unique labeling and a National Drug Code (NDC) associated with their product, emphasizing the importance of compliance with federal regulations in pharmaceutical supply. Interested vendors should note that the solicitation will be electronically issued around November 13, 2024, with a response deadline of November 27, 2024; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting offers for the procurement of Aspirin 25MG/Dipyridamole 200MG Sustained Action Capsules under solicitation number VA-25-00011491. This procurement aims to ensure a reliable supply chain for pharmaceuticals critical to various governmental health agencies, including the Department of Defense and Indian Health Services, and requires offerors to submit pricing for a base year and four option years, along with a Cost Recovery Fee of 0.5%. Compliance with the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards is mandatory, and contractors must adhere to stringent packaging and labeling guidelines while demonstrating past performance evaluations. Interested parties should contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0005 to procure Abiraterone Acetate Tablets, an essential medication for various federal health care programs. The procurement aims to secure a reliable supply of 250mg Abiraterone Acetate Tablets, with an estimated annual requirement of 71,997 bottles, to support the VA, Department of Defense, Bureau of Prisons, and other federal entities. This contract will span one base year with four optional one-year extensions, ensuring continuity of supply for critical health services. Interested offerors should monitor sam.gov for the electronic issuance of the solicitation on or about November 22, 2024, with a closing date of December 6, 2024; inquiries can be directed to Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247.
    Q517--Staffing Service Tucson
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services at the Tucson Consolidated Mail Outpatient Pharmacy (CMOP), specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The contract requires the provision of pharmacists, pharmacy technicians, and shipper/packer personnel to support the processing of over 15 million prescriptions annually, with a minimum contract value of $4 million and a maximum of $250 million over five ordering periods from April 1, 2023, to March 31, 2028. This procurement is critical for maintaining efficient pharmaceutical operations and ensuring compliance with federal regulations, including HIPAA. Interested contractors must submit their proposals by the newly established deadline of July 23, 2024, and can direct inquiries to Contract Specialist Nicholas L. Schulte at nicholas.schulte1@va.gov.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Lamotrigine Immediate Release (IR) Tablets as part of its Pharmaceutical Prime Vendor (PPV) Program. The objective of this procurement is to establish a reliable supply source for these pharmaceuticals, ensuring their availability and implementing volume-based pricing for various government agencies, including the Department of Defense and Indian Health Services. Compliance with the Drug Supply Chain Security Act, stringent packaging requirements, and adherence to FDA cGMP standards are critical components of this contract, which includes a base year and four option years. Interested bidders should contact Contract Specialist Ray Roldan at Raymond.Roldan@va.gov for further details and to submit their proposals.
    6505--Tadalafil Tablets (VA-24-00107372)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the acquisition of Tadalafil tablets under the solicitation titled "6505--Tadalafil Tablets (VA-24-00107372)." Bidders are required to provide pricing for four different dosages of Tadalafil for a base year and four option years, ensuring compliance with a 0.5% Cost Recovery Fee and the provision of unique National Drug Code (NDC) numbers for each product. This procurement is critical for maintaining a reliable pharmaceutical supply chain to support VA facilities, the Indian Health Service, and state veteran homes, thereby ensuring consistent product availability and adherence to safety and packaging standards. Interested parties should contact Contract Specialist Billy Fong at Billy.Fong@va.gov for further details regarding the submission process and requirements.
    6505--Metformin SA Tablets REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL SA Tablets, aimed at ensuring a consistent supply for various governmental entities, including the VA, Department of Defense, Bureau of Prisons, and others. The procurement will cover a one-year contract with the possibility of four additional one-year extensions, requiring offerors to provide a unique National Drug Code (NDC) number and distinct labeling for the supplied products. This initiative is critical for maintaining the availability of essential pharmaceuticals, with estimated annual requirements detailed for two groups: Other Government Agencies and the VA Repack Program. The solicitation, numbered 36E79725R0003, is scheduled for electronic release on December 3, 2024, with a closing date of December 17, 2024. Interested parties can direct inquiries to Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852, and are encouraged to monitor SAM.gov for updates.